Pages that link to "Q39608984"
Jump to navigation
Jump to search
The following pages link to Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas (Q39608984):
Displaying 50 items.
- Epigenetics Offer New Horizons for Colorectal Cancer Prevention (Q22252606) (← links)
- Epigenetics of colorectal cancer (Q24598045) (← links)
- MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer (Q26765233) (← links)
- miR-34: from bench to bedside (Q26822928) (← links)
- Role of microRNAs in mammalian spermatogenesis and testicular germ cell tumors (Q26830648) (← links)
- miRNA and mammalian male germ cells (Q26992374) (← links)
- DNA methylation and microRNA dysregulation in cancer (Q26998741) (← links)
- Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53 (Q27006998) (← links)
- P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy (Q27011547) (← links)
- MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives (Q27022292) (← links)
- Regulating miRNA by natural agents as a new strategy for cancer treatment (Q27026972) (← links)
- Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis (Q28237462) (← links)
- The p53 circuit board (Q28259725) (← links)
- MicroRNAs as potential signatures of environmental exposure or effect: a systematic review (Q28393390) (← links)
- Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling (Q28477912) (← links)
- Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. (Q33559304) (← links)
- An updated meta-analysis of 23 case-control studies on the association between miR-34b/c polymorphism and cancer risk (Q33709940) (← links)
- Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review). (Q33747273) (← links)
- Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects (Q33801377) (← links)
- Association between hsa-miR-34b/c rs4938723 T > C promoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and 6,204 controls (Q33827330) (← links)
- MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer (Q34093798) (← links)
- Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma. (Q34165233) (← links)
- Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer (Q34177065) (← links)
- miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways (Q34311399) (← links)
- Epigenetic alteration and microRNA dysregulation in cancer (Q34392645) (← links)
- Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers (Q34487177) (← links)
- KITLG is a novel target of miR-34c that is associated with the inhibition of growth and invasion in colorectal cancer cells (Q34571575) (← links)
- miR-34 – a microRNA replacement therapy is headed to the clinic (Q34640230) (← links)
- Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population (Q35049118) (← links)
- Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas (Q35057730) (← links)
- Clinically relevant microRNAs in ovarian cancer (Q35204609) (← links)
- Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer (Q35496606) (← links)
- Hypermethylation of potential tumor suppressor miR-34b/c is correlated with late clinical stage in patients with soft tissue sarcomas (Q35577760) (← links)
- Unraveling novel TF-miRNA regulatory crosstalk in metastasis of Soft Tissue Sarcoma (Q35616920) (← links)
- MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells (Q35643732) (← links)
- MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma (Q35730683) (← links)
- Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. (Q35735278) (← links)
- The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels (Q35750117) (← links)
- Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence (Q35799910) (← links)
- Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer. (Q35924210) (← links)
- MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma (Q35956645) (← links)
- microRNA signature for human pancreatic cancer invasion and metastasis (Q36225874) (← links)
- Retracted article: In vitro derivation of mammalian germ cells from stem cells and their potential therapeutic application (Q36234374) (← links)
- Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. (Q36297343) (← links)
- Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs (Q36335774) (← links)
- The significance of epigenetic alterations in lung carcinogenesis (Q36457427) (← links)
- Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells (Q36461930) (← links)
- Interrupted E2F1-miR-34c-SCF negative feedback loop by hyper-methylation promotes colorectal cancer cell proliferation (Q36543364) (← links)
- Pivots of pluripotency: the roles of non-coding RNA in regulating embryonic and induced pluripotent stem cells (Q36553617) (← links)
- Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma (Q36557866) (← links)